FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing ...

The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...

Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...

The other highlight of the Modi-Biden meeting was India’s accession to the Clean Economy and Fair Economy agreements of the ...

A team comprising lead experts from WHO's headquarters in Geneva, India office, and drug regulators from other nations ...

The other highlight of the Modi-Biden meeting was India’s accession to the Clean Economy and Fair Economy agreements of the ...

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...

Indian Patent Office to hear objections against Gilead's Lenacapavir patent claims, crucial for affordable HIV treatment ...

Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...

An Israeli-Indian treatment for knee pain caused by osteoarthritis has received Fast Track designation by the US Food and ...

Kolkata: Calcutta High Court on Thursday directed the additional solicitor-general to take instructions from the Centre about ways to import a particu.